Saggese explains the importance of effective communication in MASH management and emphasizes the need for more therapies to offer patients.
Allysa Saggese, NP
Advertisement
Allysa Saggese, NP, is a nurse practitioner at Weill Cornell.
Articles by Allysa Saggese, NP
Saggese describes recent evolutions in MASH care with the FDA approval of semaglutide and the continued importance of diet, physical activity, and weight management.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Interim Phase 3 VISIONARY Data Show Sibeprenlimab Preserved Kidney Function in IgA Nephropathy
2
POCUS is Standard of Care in Critical Care, With Rhea Votipka, NP
3
Trials and Guidelines Shaping Critical Care, With Rhea Votipka, NP
4
Navigating a New Era of PH Management as an APP, With Susanne McDevitt, DNP
5